{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T13:01:40Z","timestamp":1777640500019,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Russian Scientific Fund","award":["14-50-00069"],"award-info":[{"award-number":["14-50-00069"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.ejmech.2015.06.022","type":"journal-article","created":{"date-parts":[[2015,6,25]],"date-time":"2015-06-25T03:50:04Z","timestamp":1435204204000},"page":"334-347","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"special_numbering":"C","title":["Probing the \u2018bipolar\u2019 nature of the carbonic anhydrase active site: Aromatic sulfonamides containing 1,3-oxazol-5-yl moiety as picomolar inhibitors of cytosolic CA I and CA II isoforms"],"prefix":"10.1016","volume":"101","author":[{"given":"Mikhail","family":"Krasavin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikhail","family":"Korsakov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikhail","family":"Dorogov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiziano","family":"Tuccinardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nurcan","family":"Dedeoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2015.06.022_bib1","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1073\/pnas.70.7.1986","article-title":"Carbon dixoide hydration activity of carbonic anhydrase: paradoxical consequences of the unusually rapid catalysis","volume":"70","author":"Khalifah","year":"1973","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"10.1016\/j.ejmech.2015.06.022_bib2","doi-asserted-by":"crossref","DOI":"10.1152\/physrev.1967.47.4.595","article-title":"Carbonic anhydrase chemistry, physiology, and inhibition","volume":"47","author":"Maren","year":"1967","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejmech.2015.06.022_bib3","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrsases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2015.06.022_bib4","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3109\/14756366.2013.761876","article-title":"Carbonic anhydrases: from biomedical applications of the inhibitors and activators to biotechnologic use for CO2 capture","volume":"28","author":"Supuran","year":"2013","journal-title":"J.\u00a0Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.06.022_bib5","doi-asserted-by":"crossref","first-page":"921","DOI":"10.2174\/138955706777934946","article-title":"New zinc binding motifs in the design of selective carbonic anhydrase inhibitors","volume":"6","author":"Winum","year":"2006","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.06.022_bib6","series-title":"Carbonic Anhydrase: Its Inhibitors and Activators","first-page":"67","author":"Supuran","year":"2004"},{"key":"10.1016\/j.ejmech.2015.06.022_bib7","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ejmech.2014.02.023","article-title":"4-Functionalized 1,3-diarylpyrazoles bearing benzenesulfonamide moiety as selective potent inhibitors of the tumor associated carbonic anhydrase isoforms IX and XII","volume":"76","author":"Khloya","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.06.022_bib8","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ejmech.2013.06.003","article-title":"Design and synthesis of novel 4-(4-oxo-2-arylthiazolidin-3-yl) benzenesulfonamides as selective inhibitors of carbonic anhydrase IX over I and II with potential anticancer activity","volume":"66","author":"Suthar","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.06.022_bib9","doi-asserted-by":"crossref","first-page":"5427","DOI":"10.1016\/j.bmcl.2004.07.087","article-title":"Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic\/tumor-associated carbonic anhydrase isozymes I, II and IX with sulfonamides incorporating 1,2,4-triazine moieties","volume":"14","author":"Garaj","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2015.06.022_bib10","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/cmdc.201000044","article-title":"Identification of potent and selective human carbonic anhydrase VII (CA VII) inhibitors","volume":"5","author":"Gitto","year":"2010","journal-title":"Chem. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.06.022_sref11","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1002\/pro.5560071201","article-title":"Structural analysis of inhibitor binding to human carbonic anhydrase II","volume":"7","author":"Boriack-Sjodin","year":"1998","journal-title":"Protein Sci."},{"key":"10.1016\/j.ejmech.2015.06.022_bib11b","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3109\/14756366.2012.672983","article-title":"Structure-based drug discovery of carbonic anhydrase inhibitors","volume":"27","author":"Supuran","year":"2012","journal-title":"J.\u00a0Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.06.022_bib12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/newbio235131a0","article-title":"Crystal structure of human carbonic anhydrase C","volume":"235","author":"Liljas","year":"1972","journal-title":"Nat. New. Biol."},{"key":"10.1016\/j.ejmech.2015.06.022_bib13a","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1517\/17460441.2013.795145","article-title":"Exploiting the hydrophobic and hydrophilic binding sites for designing carbonic anhydrase inhibitors","volume":"8","author":"De Simone","year":"2013","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2015.06.022_bib13b","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1021\/cr200176r","article-title":"Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?","volume":"112","author":"Alterio","year":"2012","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2015.06.022_bib14","doi-asserted-by":"crossref","first-page":"8371","DOI":"10.1039\/c0cc02707c","article-title":"Selective hydrophobic pocket binding observed within the carbonic anhydrase II active site accommodate different 4-substituted-ureidobenzenesolfinamides and correlate to inhibitor potency","volume":"46","author":"Pacchiano","year":"2010","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2015.06.022_bib15","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1021\/jm501798g","article-title":"Carbonic anhydrase inhibitors with dual-tail moieties to match the hydrophobic and hydrophilic halves of the carbonic anhydrase active site","volume":"58","author":"Tanpure","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.06.022_bib16","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1055\/s-0029-1219374","article-title":"Methodology for the synethsis of substituted 1,3-oxazoles","author":"Williams","year":"2010","journal-title":"Synlett"},{"key":"10.1016\/j.ejmech.2015.06.022_bib17","doi-asserted-by":"crossref","first-page":"5055","DOI":"10.1016\/j.bmcl.2014.09.016","article-title":"Synthesis and structure\u2013activity relationship of 4-azaheterocycle benzenesulfonamide derivatives as new microtubule-targeting agents","volume":"24","author":"Yang","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2015.06.022_bib18","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0223-5234(91)90065-U","article-title":"Thiophene isosteres: synthesis and biological evaluation of 3-Substituted derivatives of 4-Phenyl-2-thioxobenzo[4,5]thieno[2,3-d]pyrimidine","volume":"26","author":"Vega","year":"1991","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.06.022_bib19","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2174\/138161208783877947","article-title":"Diuretics: from classical carbonic anhydrase inhibitors to novel applications of the sulfonamides","volume":"14","author":"Supuran","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejmech.2015.06.022_bib20","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2174\/138161208783877866","article-title":"The development of topically acting carbonic anhydrase inhibitors as antiglaucoma agents","volume":"14","author":"Micione","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejmech.2015.06.022_bib21","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nrd3554","article-title":"Interfering with pH regulation in tumours as a therapeutic strategy","volume":"10","author":"Neri","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2015.06.022_bib22","unstructured":"ClinicalTrails.gov: Safety Study of SLC-0111 in Subjects With Advanced Solid Tumours - Full Text View \u2013 https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02215850."},{"key":"10.1016\/j.ejmech.2015.06.022_bib23","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/S0021-9258(18)62326-9","volume":"246","author":"Khalifah","year":"1971","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2015.06.022_bib24a","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3109\/14756366.2011.641015","volume":"28","author":"Maresca","year":"2013","journal-title":"J.\u00a0Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.06.022_bib24b","doi-asserted-by":"crossref","first-page":"845","DOI":"10.3109\/14756366.2011.621122","volume":"27","author":"Ekinci","year":"2012","journal-title":"J.\u00a0Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.06.022_bib24c","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3109\/14756366.2011.643303","volume":"28","author":"Ekinci","year":"2013","journal-title":"J.\u00a0Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.06.022_bib24d","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3109\/14756366.2012.658788","volume":"28","author":"Alp","year":"2013","journal-title":"J.\u00a0Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.06.022_bib25","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1006\/jmbi.1994.1655","article-title":"Drug-protein interactions. Refined structures of three sulfonamide drug complexes of human carbonic anhydrase I enzyme","volume":"243","author":"Chakravarty","year":"1994","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.ejmech.2015.06.022_bib26","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.bmcl.2005.09.040","article-title":"Carbonic anhydrase inhibitors: Valdecoxib binds to a different active site region of the human isoform II as compared to the structurally related cyclooxygenase II \u201cselective\u201d inhibitor celecoxib","volume":"16","author":"Di Fiore","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2015.06.022_bib27","doi-asserted-by":"crossref","first-page":"16233","DOI":"10.1073\/pnas.0908301106","article-title":"Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX","volume":"106","author":"Alterio","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.ejmech.2015.06.022_bib28","doi-asserted-by":"crossref","first-page":"9545","DOI":"10.1073\/pnas.161301298","article-title":"Crystal structure of the dimeric extracellular domain of human carbonic anhydrase XII, a bitopic membrane protein overexpressed in certain cancer tumor cells","volume":"98","author":"Whittington","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.ejmech.2015.06.022_bib29","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The protein data bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2015.06.022_bib30","series-title":"AMBER, Version 11","author":"Case","year":"2010"},{"key":"10.1016\/j.ejmech.2015.06.022_bib31a","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1021\/ci600469w","article-title":"Analysis of human carbonic anhydrase II: docking reliability and receptor-based 3D-QSAR study","volume":"47","author":"Tuccinardi","year":"2007","journal-title":"J.\u00a0Chem. Inf. Model"},{"key":"10.1016\/j.ejmech.2015.06.022_bib31b","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1021\/ci700214j","article-title":"Homology modeling and receptor-based 3D-QSAR study of carbonic anhydrase IX","volume":"47","author":"Tuccinardi","year":"2007","journal-title":"J.\u00a0Chem. Inf. Model."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523415300969?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523415300969?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,15]],"date-time":"2022-05-15T07:05:31Z","timestamp":1652598331000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523415300969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":37,"alternative-id":["S0223523415300969"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2015.06.022","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Probing the \u2018bipolar\u2019 nature of the carbonic anhydrase active site: Aromatic sulfonamides containing 1,3-oxazol-5-yl moiety as picomolar inhibitors of cytosolic CA I and CA II isoforms","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2015.06.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}